Seleccione idioma:  
RTICC 2013
Programas RTICC
Seguimiento cientifico
Sobre la RTICC 2013-2016 » Work Packages

The list of Scientific Programs contemplated in this proposal for a new cancer RETIC sponsored by ISCIII for the period 2013-2016 represents a natural evolution of the previously experienced vertical research Lines and horizontal Platforms held in the context of the Cooperative Cancer research networks active in Spain since 2003.

Indeed, the Executive committees of the prior RTICC editions have always endeavored to review and modify their research programs with an aim at improving the quantity and quality of the cooperative cancer research performed in the RTICCs as well as increasing the ability of the RTICC networked groups to collaborate and compete at the international level. With similar intent, the ISCIII has now included in the current RETIC call a number of additional requisites, not previously contemplated in previous RTICCs, such as the predominantly traslational nature of the research to be performed, the emphasis on bigger size and productivity of the networked groups, and the requirement for a minimum 50% of clinical research groups in the final roster of the network.

Taking into account the above mentioned need for quality improvements and the new selection criteria contained in the ISCIII call, recent deliberations of the Executive Committee of the currently active RTICC produced in January 2012 a suggested list of 8 separate Scientific Programs that is basically coincident with the set of Programs listed for all potential cancer RETIC proposals in the call for new RETIC applications published by SCIII in the BOE issue of March2012.

After defining the specific Programs to be included in the proposal, the CE also designed a detailed calendar and procedure for selection of the most appropriate PI candidates for those Programs in a competitive process open not only to previous members of RTICC but also to PI candidates from other scientific organizations or networks. Interestingly, an important number of groups from the currently active RTICC became fused into a single new group inorder to present their candidacy to this new cancer RETIC. In parallel, the EC also elected a Coordinator for each proposed scientific Program who was put in charge of piloting and managing the preparation of the specific research programs and work packages and defining the expected contributions and matching budgets assigned to each participating group. All these preparations and selection processes were completed at the end of May, and a final list of programs, coordinators and group PIs was released by the EC after its meeting of may 28th.

The list of Programs, Work packages, Coordinator and Group PIs included in this new RETIC on cancer is as follows:

Work Packages
Coordinación RTICC
03/03/2017 | Otras reuniones
13/11/2016 | Otras reuniones
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
Martinez D, Navarro A, Martinez-Trillos A, Molina-Urra R, Gonzalez-Farre B, Salaverria I, Nadeu F, Enjuanes A, Clot G, Costa D, Carrio A, Villamor N, Colomer D, Martinez A, Bens S, Siebert R, Wotherspoon A, Beà S, Matutes E, Campo E
Am J Surg Pathol  2016.  2.  192-201.  PMID: 26426381. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

Present and future of personalized medicine in CLL.
Montserrat E, Bauman T, Delgado J
Best Pract Res Clin Haematol  2016.  1.  100-110.  PMID: 27742064. 

Maintenance therapy in chronic lymphocytic leukaemia.
Delgado J, Montserrat E
Lancet Haematol  2016.  9.  e399-400.  PMID: 27570083. 

[Advances in the treatment of chronic lymphocytic leukaemia].
Mozas P, Delgado J
Med Clin (Barc)  2016.  10.  447-454.  PMID: 27431885. 

The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia.
Ortíz-Maldonado V, Mozas P, Delgado J
Ther Adv Hematol  2016.  6.  321-329.  PMID: 27904736. 

The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, EHA Roadmap for European Hematology Research.
Haematologica  2016.  2.  115-208.  PMID: 26819058. 

Diffuse Large B-Cell Lymphoma: Should Limited-Stage Patients Be Treated Differently?
Giné E, Sehn LH
Hematol Oncol Clin North Am  2016.  6.  1179-1194.  PMID: 27888874. 

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
Queirós AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russiñol N, Castellano G, Beà S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverría I, van de Werken HJ, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Giné E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Martín-Subero JI
Cancer Cell  2016.  5.  806-821.  PMID: 27846393. 
Grupos colaboradores: RD12/0036/0063 , RD12/0036/0036 , RD12/0036/0023

Genetic evolution in chronic lymphocytic leukaemia.
Delgado J, Villamor N, López-Guillermo A, Campo E
Best Pract Res Clin Haematol  2016.  1.  67-78.  PMID: 27742073. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

Martín-Vañó S, Berbegall AP, Navarro L, Blanquer-Maceiras M, Beléndez-Bieler C, Garrido-Colino C, Navarro S, Rosa Noguera Salvá

Ministerio de Economia y Competitividad
Red Temática Investigación Cooperativa Sanitaria
Rticc 2012
Red Temática Investigación Cooperativa en Cáncer (RTICC)
Centro de Investigación Cáncer - Campus Miguel de Unamuno - 37007 - Salamanca
(+34) 923294803 - sec.rticc[arroba]usal.es
Sobre la RTICC Programas RTICC Ofertas de empleo y Agenda Seguimiento científico
Red Temática de Investigación Cooperativa en Cáncer · © Copyright 2013 · sec.rticc[arrroba]usal.es · diseño web: detrazos